Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study

As an emerging hotspot for patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC), neoadjuvant immunochemotherapy (nICT) is safe and feasible. Pathological complete response (pCR) is considered to be an important therapeutic effect of neoadjuvant therapy. However, few studies ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jifeng, Wang, Liang, Yang, Xun, Chen, Qixun, Cheng, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901900/
https://www.ncbi.nlm.nih.gov/pubmed/35880397
http://dx.doi.org/10.17305/bjbms.2022.7696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901900/
https://www.ncbi.nlm.nih.gov/pubmed/35880397
http://dx.doi.org/10.17305/bjbms.2022.7696

Ejemplares similares